Caring for 'Very Important Patients'--Ethical Dilemmas and Suggestions for Practical Management.
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Journal:
PLoS Med
13(2):e1001955
Publish Date:
2016-02-01
Author Profiles:
A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.
Journal:
JAMA Intern Med
176(2):263-5
Publish Date:
2016-02-01
Author Profiles:
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Journal:
PLoS Med
13(2):e1001955
Publish Date:
2016-02-01
Author Profiles:
In Favour of Medical Dissensus: Why We Should Agree to Disagree About End-of-Life Decisions.
Journal:
Bioethics
30(2):109-18
Publish Date:
2016-02-01
Author Profiles:
Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size Companies.
Journal:
Health Aff (Millwood)
35(2):219-26
Publish Date:
2016-02-01
Author Profiles:
Medically Inappropriate or Futile Treatment: Deliberation and Justification.
Journal:
J Med Philos
41(1):90-114
Publish Date:
2016-02-01
Author Profiles: